Riskpilot← Back to searchSign inGet full accessBromma Estetik AB
ABActiveOrg 5591438568Ångermannagatan 172Medical specialists activities · NACE 8622Est. 20181 employees
Revenue 2024
SEK 1,8M
+21% vs 2023
EBITDA margin
18.7%
-21% vs 2023
Equity ratio
38.5%
Financial strength
Net profit 2024
SEK 220K
-14% vs 2023
| Revenue | SEK 1,8M | +21% |
| EBITDA | SEK 334K | -21% |
| Net profit | SEK 220K | -14% |
| Total assets | SEK 1,4M | +36% |
| Equity | SEK 525K | +72% |
| Employees | 1 | — |
Legal name
Bromma Estetik AB
Org number
5591438568
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
4 januari 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva medicinska konsultationer och behandlingar såsom estetisk laserkirurgi och kosmetikrelaterade behandlingar. Bolaget ska bedriva handel med medicinska preparat och produkter. Konsultuppdrag inom hälso- och sjukvård som legitimerad läkare, specialist i allmänmedicin samt därmed förenlig verksamhet.
Address
Ångermannagatan 172
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 752 | 1 570 | 1 427 | 1 467 | 1 780 |
| Staff expenses | — | — | −740 | −585 | −1 006 |
| EBITDA | 127 | 488 | 141 | 424 | 334 |
| Depreciation & amort. | −39 | −39 | −51 | −95 | −56 |
| EBIT | 88 | 449 | 91 | 330 | 278 |
| Net financials | −20 | −21 | −0 | −2 | 0 |
| Profit before tax | 68 | 328 | 190 | 328 | 278 |
| Tax | −15 | −71 | −41 | −73 | −58 |
| Net profit | 53 | 257 | 150 | 255 | 220 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 796 | 1 530 | 1 293 | 1 005 | 1 365 |
| Equity | 131 | 387 | 537 | 305 | 525 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 666 | 1 042 | 756 | 700 | 840 |
| Total debt | 666 | 1 042 | 756 | 700 | 840 |
EBITDA margin
18.7%
This company
15.8%
Market median
+18% vs market
20202024
Equity ratio
38.5%
This company
38.2%
Market median
+1% vs market
20202024
Return on equity
41.9%
This company
18.4%
Market median
+128% vs market
20202024
Net profit margin
12.3%
This company
8.1%
Market median
+52% vs market
20202024
Asset turnover
1.30×
This company
1.12×
Market median
+16% vs market
20202024
Debt / equity
1.60×
This company
0.62×
Market median
-158% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Bromma Estetik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Josef Faris Faik Sayegh | Board of Directors | 0 companies |
| Penelope Ghosn | Deputy Board Member | 0 companies |